You are here: All Products  > Zenas, a US-China Biopharma, Announces $480 Million Deal for Autoimmune Therapy

Zenas, a US-China Biopharma, Announces $480 Million Deal for Autoimmune Therapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products